glp-1 agonist eli lilly GLP-1s & Beyond: Understanding Incretin Mimetic Opportunities Eli Lilly Orforglipron Diabetes Trial

Crossmon, G

Critical challenges included insufficient sample size reducing statistical power, reliance on self-reported exposure data introducing recall bias, and inadequate control for confounding factors such as smoking and alcohol consumption

For genetically predicted acetyl-carnitine, we also found an association with higher triglycerides (0.06, 95% CI 0.04 to 0.07) and lower HDL-cholesterol ( 0.03, 95% CI 0.05 to 0.02) (Additional file 2: Fig

At the hypothalamic level, GHRP-6 suppresses somatostatin release and stimulates endogenous GHRH release, creating a dual hypothalamic action that amplifies the pituitary GH signal

Egamberdieva et al., 2018)

Both forms are designed to improve delivery, but they have not been adequately compared against each other in robust human trials